[Clinical evaluation of a new pharmacological association with hypotensive effect. Statistical presentation of results].
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002752:Chlorthalidone / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004361:Drug Tolerance; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007546:Isoquinolines / Q000494:pharmacology / Q000627:therapeutic use; D008274:Magnesium / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000494:pharmacology / Q000627:therapeutic use; D010634:Phenobarbital / Q000494:pharmacology / Q000627:therapeutic use; D008517:Phytotherapy; D010946:Plants, Medicinal; D011926:Rauwolfia / Q000494:pharmacology / Q000627:therapeutic use
D000959:Antihypertensive Agents; D004338:Drug Combinations; D007546:Isoquinolines; D010208:Papaverine; D008274:Magnesium; D002752:Chlorthalidone; D010634:Phenobarbital
Valutazione clinica di una nuova associazione farmacologica ad effetto ipotensivo. Elaborazione statistica dei risultati.